Showing results (11-20 of 219) with videos related to
Sort By:
Pageof 22
Advances in Therapy|October 6, 2011
Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factorsAlpesh N Amin, Mehul Jhaveri, Jay LinClinicoeconomics and Outcomes Research : CEOR|January 6, 2017
Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diabetes in the USJay Lin, Melissa Lingohr-Smith, Tao FanPostgraduate Medicine|March 16, 2017
Safety and efficacy of a glucagon-like peptide-1 receptor agonist added to basal insulin therapy versus basal insulin with or without a rapid-acting insulin in patients with type 2 diabetes: results of a meta-analysisCarol H Wysham, Jay Lin, Louis KuritzkyJournal of Medical Economics|February 23, 2012
Temporal pattern and costs of rehospitalization in atrial fibrillation/atrial flutter patients with one or more additional risk factorsAlpesh N Amin, Mehul Jhaveri, Jay LinClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 20, 2011
Preventing venous thromboembolism following orthopedic surgery in the United States: impact of special populations on clinical outcomesSteven B Deitelzweig, Jay Lin, Grace LinAdvances in Therapy|August 20, 2009
National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the USMichael H Kim, Jay Lin, Charles KreilickAdvances in Therapy|April 15, 2010
Need to improve thromboprophylaxis across the continuum of care for surgical patientsAlpesh N Amin, Jay Lin, Amy RyanAdvances in Therapy|March 14, 2013
Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophreniaSteve Offord, Jay Lin, Dario Mirski, et al.Clinical Advances in Hematology & Oncology : H&O|February 12, 2009
Appropriate thromboprophylaxis in hospitalized cancer patientsAlpesh Amin, Stephen Stemkowski, Jay Lin, et al.The Journal of Behavioral Health Services & Research|April 13, 2013
Healthcare cost reductions associated with the use of LAI formulations of antipsychotic medications versus oral among patients with schizophreniaJay Lin, Bruce Wong, Steve Offord, et al.Pageof 22